NH HB1702

Requires medical facilities and pharmacies that prescribe, dispense, or administer chemical abortion drugs (including mifepristone) to post conspicuous signs at least 8.5" x 11" with 3/4-inch bold lettering informing patients that the effects of mifepristone may be reversible if the second pill has not been taken

Specifies sign placement requirements: private offices and surgical clinics must post in waiting and consultation rooms; hospitals and clinics must post in admission areas; pharmacies must post at prescription counters and drive-through windows

Establishes a class B felony penalty for health care providers or pharmacies that knowingly violate the notice requirements

Authorizes civil actions by women who receive chemical abortion drugs without being provided the required notice, allowing recovery of monetary damages for psychological and physical injuries

Takes effect 60 days after passage, with indeterminable fiscal impact on state and local expenditures related to potential prosecution and incarceration costs